Article
In vivo metabolism of the new designer drug 1-(4-methoxyphenyl)piperazine (MeOPP) in rat and identification of the human cytochrome P450 enzymes responsible for the major metabolic step.
Xenobiotica; the fate of foreign compounds in biological systems - 1 Feb 2004
Staack R F, Theobald D S, Paul L D, Springer D, Kraemer T, Maurer H H
Abstract excerpt
1. The in vivo metabolism of 1-(4-methoxyphenyl)piperazine (MeOPP), a novel designer drug, was studied in male Wistar rats. 2. MeOPP was mainly O-demethylated to 1-(4-hydroxyphenyl)piperazine (4-HO-PP) in addition to degradation of the piperazine moiety. 3. O-demethylation, the major metabolic st...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.